Dalton Pharma Services Expands its Contract Analytical Services


Dalton Pharma Services announced the expansion of its Contract analytical services with the commissioning of two validated LC-MS/MS instruments which have been qualified for GMP testing of pharmaceutical products. The new equipment will assist in the identification, quantification of related substances, pharmaceutical degradation products and impurities to support the preparation of registration dossiers for clients' drug development programs.

"Our commitment to accelerate the drug discovery and development process continues as we add to our state-of-the-art instrumentation to support GMP API synthesis, sterile dose formulation and sterile fill, method validation and other outsourced analytical projects including stability studies, bioanalytical development and analysis," said Peter Pekos, President and CEO. Dalton continues to develop and grow its analytical capabilities to enhance it's commitment to quality, responsiveness, flexibility and innovation through the supply of unparalleled contract pharmaceutical development services.

Other news from the department business & finance

More news from our other portals